MES of the Future
Manufacturing Execution Systems (MES) of the future brings together both biomanufacturers and supply partners to define future user requirements and accelerate solutions for an MES of the future that works in sync with the biomanufacturing industry needs and growth.
Industry needs are not clearly defined and understood
Current MES systems are expensive, slow to implement, and lack the flexibility/agility/openness to be efficiently updated and implemented. The experience of many biomanufacturing companies is that integrating an MES product into a production landscape involves defining, developing, and implementing expensive, custom-built interfaces to effectively extract and combine data. MESs have evolved from basic data collection tools into sophisticated systems that drive operational excellence. However, their full potential is only unlocked when integrated seamlessly with other software solutions. Understanding your digital plant maturity across the board is key to making the right decisions. New requirements and technologies are frequently emerging meaning that current approaches quickly become outdated.
Data management is becoming increasingly difficult to navigate through as each supplier adopts their own unique approach in configuring and managing data at each stage of the manufacturing process. The absence of a standardized framework for handling priority data poses challenges for manufacturers.
The definition of an MES is changing or overlapping with CMMS, LIMS, PLM, etc, clear interface roles and responsibilities are not readily available to the industry and businesses are making decisions in silo. “MES” or “execution needs” are siloed across the drug lifecycle. Tech transfer of execution definitions/recipes from pre-clinical to clinical to commercial have a direct impact on MES, yet this is not fully understood and considered.
Existing supply partners do not fully understand the biomanufacturing industry needs as they are not easily contextualised and understood or built into product roadmaps, which exacerbates the problem long term.
Manufacturers and supply partners working together
Following the publication of the MES Manifesto, the goal of the workstream is now to provide a vehicle for manufacturers and supply partners to work together to develop potential solutions and a common industry-wide view that will accelerate change and overcome existing challenges and limitations. The MES of the Future program is a way to collaborate and share knowledge with the biomanufacturers and MES supply partners. It improves the understanding of the value proposition, challenges, and best practice for MES integration in the biopharmaceutical industry.
The team are empowered together to accelerate progress in defining the MES of the Future, including:
- The optimization of production costs and manufacturing efficiency by improving best practices, streamlining processes, and enhancing seamless data flows between MES and other systems
- Increased speed to market through dynamic and agile integrations
- Understanding what level of digital plant maturity is right for your site in regards to MES
- Practical guidance and clear recommendations on how to successfully integrate MES in a given IT ecosystem, which can enable the prevention of common mistakes, optimizing the implementation process
- Increase performance and scalability of MES systems
More related workstreams
Our workstreams focus on the areas with the greatest impact across the industry. Led by science, our members are problem-solving today’s sustainability issues. By working with the regulatory governance community, they are also creating future-ready outcomes for the industry.
To find out more about how BioPhorum can help your business, enter your details below and a member of our team will be in touch.